Product Images Linezolid

This appears to be a graph showing the plasma concentration of Linezolid (an antibiotic) over time after a 600mg oral dose given every 12 hours. The X-axis shows the time after the dose (in hours) and the Y-axis shows the plasma concentration (in pg/mL).*

The text appears to be a product label or package insert for Linezolid Injection, containing 600 mg per 300 mL of solution for intravenous use only. The product should be stored at controlled room temperature, protected from light and not frozen. Each milliliter contains Linezolid, Dextrose, Sodium Citrate, Citric Acid and Water for Injection, with pH adjusted using sodium hydroxide or hydrochloric acid. The solution should not be mixed with other medications or used in series connections. It advises checking for leaks before using and for the yellow discoloration which doesn't affect its potency. The dosage should be in accordance with the package insert, and unused portions should be discarded. The product is made by Piramal Critical Care, and the packaging/labelling includes a Novaplus registered trademark. The LOT/EXP information should be available on the back.*

This is a description of Linezolid Injection, with a concentration of 600 mg/300 mL at 2 mg/ml meant for intravenous use. The product comes in ten 300 mL single-dose bags under the brand name novaplus.*

This is a drug information label for Linezolid, which is an injection used intravenously. The label provides instructions for opening the container, storage, and usage of this drug. The label also contains information about the ingredients present in the injection and manufacturer details. Cautionary instructions such as the need to check for any leaks before use are also mentioned. The label also mentions a registry, Novaplus, which is a trademark of Vizient, Inc. The usual dosage and other details are mentioned in the package insert. The text also highlights that Linezolid is sensitive to light, and the overwrap should be retained before use.*